Boston Scientific

Boston Scientific (BSX) Extends Losing Streak: What Tuesday’s Close Means Before the Bell on December 10, 2025

Boston Scientific Corporation (NYSE: BSX) heads into Wednesday’s U.S. trading session looking bruised but far from broken. On Tuesday, December 9, 2025, Boston Scientific stock slipped about 1.4% to roughly $92.5 per share, on heavier‑than‑usual volume of around 12.7 million

10 December 2025

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

December 3, 2025 – Market close snapshot and latest news for Boston Scientific Corporation (NYSE: BSX). Boston Scientific Corporation stock remains a closely watched name in large‑cap medical technology as 2025 winds down. On December 3, 2025, the BSX share

4 December 2025

Financial News · Insider Trading · Investment Analysis · Medical Devices · NYSE:BSX · Stock Market

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price

19 November 2025

Company News · Healthcare Investments · Market Trends · Medical Technology · NYSE:BSX · Stock Analysis

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter

22 October 2025

Earnings Reports · Investing · Market News · Medical Technology · Stocks